Catastrophic antiphospholipid syndrome: An orchestra with several musicians

Israel Medical Association Journal

Volumn 16, Issue 9, 2014, Pages 585-586

  Rodríguez Pintó, Ignasi ^a,b,c   Soriano, Alessandra ^b,c   Espinosa, Gerard ^a   Shoenfeld, Yehuda ^b,c   Cervera, Ricard ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid antibodies (aPL); Catastrophic antiphospholipid syndrome (CAPS); Ferritin; Hyperferritinemia

Indexed keywords

FERRITIN; PHOSPHOLIPID ANTIBODY; TOLL LIKE RECEPTOR 4;

ANTIPHOSPHOLIPID SYNDROME; BACTEREMIA; EDITORIAL; HUMAN; HYPERFERRITINEMIA; INCIDENCE; INFECTION; TERMINAL DISEASE; THROMBOPHLEBITIS; THROMBOSIS; UPREGULATION; BLOOD; BLOOD CLOTTING; COMPLICATION; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; FERRITINS; HUMANS; INFECTION; NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 84908096259     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19 (4): 508-12.
2. Centers for Disease Control. Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep 1981; 30 (21): 250-2.
3. Cervera R, Piette J-C, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46 (4): 1019-27.
4. de Meis E, Brandao LR, Capella FC, Garcia JAP, Gregory SC. Catastrophic antiphospholipid syndrome in cancer patients: an interaction between clotting, autoimmunity and tumor growth? IMAJ 2014; 16: 544-7.
5. Ortega-Hernandez O-D, Agmon-Levin N, Blank M, Asherson RA, Shoenfeld Y. The physiopathology of the catastrophic antiphospholipid (Asherson’s) syndrome: compelling evidence. J Autoimmun 2009; 32 (1): 1-6.
6. Cervera R, Bucciarelli S, Plasin MA, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun 2009; 32 (3-4): 240-5.
7. Trousseau A. Plegmasia alba dolens. In: Lectures on Clinical Medicine, delivered at the Hotel Dieu, Paris, 1865: 654-712.
8. Cervera R, Asherson RA, Acevedo ML, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004; 63 (10): 1312-17.
9. Meroni P, Chighizola C. Pathophysiology of the antiphospholipid syndrome (APS) Physiopathologie du syndrome des antiphospholipides. Le Rev Méd Int 2012; 33S: 2-4.
10. Berman H, Rodriguez-Pinto I, Cervera R, et al. Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the “caps registry.” Autoimmun Rev 2014; 13 (2): 157-62.
11. Espinosa G, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome and sepsis. A common link? J Rheumatol 2007; 34 (5): 923-6.
12. Rosario C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 2013; 11: 185.
13. Zandman-Goddard G, Shoenfeld Y. Hyperferritinemia in autoimmunity. IMAJ 2008; 10 (1): 83-4.
14. Zandman-Goddard G, Orbach H, Agmon-Levin N, et al. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol 2013; 44 (1): 23-30.
15. Da Costa R, Szyper-Kravitz M, Szekanecz Z, et al. Ferritin and prolactin levels in multiple sclerosis. IMAJ 2011; 13 (2): 91-5.
16. Agmon-Levin N, Rosario C, Katz B-SP, et al. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). Lupus 2013; 22 (13): 1327-35.